U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Recurrent Gastric Adenocarcinoma

MedGen UID:
1649479
•Concept ID:
C0863168
•
Neoplastic Process

Definition

The reemergence of gastric adenocarcinoma after a period of remission. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVRecurrent Gastric Adenocarcinoma

Professional guidelines

PubMed

Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA
J Natl Compr Canc Netw 2022 Feb;20(2):167-192. doi: 10.6004/jnccn.2022.0008. PMID: 35130500
Current treatment and recent progress in gastric cancer.
Joshi SS, Badgwell BD
CA Cancer J Clin 2021 May;71(3):264-279. Epub 2021 Feb 16 doi: 10.3322/caac.21657. PMID: 33592120Free PMC Article
Updates on Management of Gastric Cancer.
Johnston FM, Beckman M
Curr Oncol Rep 2019 Jun 24;21(8):67. doi: 10.1007/s11912-019-0820-4. PMID: 31236716

Recent clinical studies

Etiology

Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y
Anticancer Res 2019 May;39(5):2583-2589. doi: 10.21873/anticanres.13381. PMID: 31092456
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
Nakai Y, Ishigami H, Isayama H, Sasaki T, Kawakubo K, Kogure H, Emoto S, Yamaguchi H, Kitayama J, Yamamoto N, Sasahira N, Hirano K, Tada M, Koike K
J Gastroenterol Hepatol 2012 Dec;27(12):1796-800. doi: 10.1111/j.1440-1746.2012.07241.x. PMID: 22849855
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R
Nucl Med Commun 2012 Sep;33(9):960-6. doi: 10.1097/MNM.0b013e328355b694. PMID: 22692579
A prognostic model in patients who receive chemotherapy for metastatic or recurrent gastric cancer: validation and comparison with previous models.
Koo DH, Ryoo BY, Kim HJ, Ryu MH, Lee SS, Moon JH, Chang HM, Lee JL, Kim TW, Kang YK
Cancer Chemother Pharmacol 2011 Oct;68(4):913-21. Epub 2011 Feb 3 doi: 10.1007/s00280-011-1561-8. PMID: 21290247
Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.
Tsushima T, Hironaka S, Boku N, Machida N, Yamazaki K, Yasui H, Taku K, Fukutomi A, Onozawa Y
Gastric Cancer 2010 Nov;13(4):245-50. Epub 2010 Dec 3 doi: 10.1007/s10120-010-0566-z. PMID: 21128060

Diagnosis

A potential treatment option for elderly non-Hodgkin lymphoma patients with multiple comorbidities: Two case reports and literature review.
Lee S, Jeon H, Park S, Lee S, Chang HJ, Eo W
Explore (NY) 2021 May-Jun;17(3):265-269. Epub 2020 Oct 21 doi: 10.1016/j.explore.2020.10.004. PMID: 33132079
Hemobilia in the Setting of Billroth II Anatomy and Recurrent Gastric Adenocarcinoma.
Berry R, Weissman S, Mehta TI, Vartanian T, Tabibian JH
J Gastrointest Cancer 2021 Mar;52(1):328-331. doi: 10.1007/s12029-020-00437-5. PMID: 32572812
Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y
Anticancer Res 2019 May;39(5):2583-2589. doi: 10.21873/anticanres.13381. PMID: 31092456
Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
Chan DY, Syn NL, Yap R, Phua JN, Soh TI, Chee CE, Nga ME, Shabbir A, So JB, Yong WP
J Gastrointest Surg 2017 Mar;21(3):425-433. Epub 2016 Dec 15 doi: 10.1007/s11605-016-3336-3. PMID: 27981493
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R
Nucl Med Commun 2012 Sep;33(9):960-6. doi: 10.1097/MNM.0b013e328355b694. PMID: 22692579

Therapy

Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naïve patients with HER2-positive, previously treated, advanced, or recurrent gastric cancer (JFMC45-1102).
Nishikawa K, Takahashi T, Takaishi H, Miki A, Noshiro H, Yoshikawa T, Nishida Y, Iwasa S, Miwa H, Masuishi T, Boku N, Yamada Y, Kodera Y, Yoshida K, Morita S, Sakamoto J, Saji S, Kitagawa Y
Int J Cancer 2017 Jan 1;140(1):188-196. Epub 2016 Oct 6 doi: 10.1002/ijc.30383. PMID: 27521503Free PMC Article
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
Nakai Y, Ishigami H, Isayama H, Sasaki T, Kawakubo K, Kogure H, Emoto S, Yamaguchi H, Kitayama J, Yamamoto N, Sasahira N, Hirano K, Tada M, Koike K
J Gastroenterol Hepatol 2012 Dec;27(12):1796-800. doi: 10.1111/j.1440-1746.2012.07241.x. PMID: 22849855
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.
Yoshikawa T, Tsuburaya A, Hirabayashi N, Yoshida K, Nagata N, Kodera Y, Takahashi N, Oba K, Kimura M, Ishikura S, Miyashita Y, Sakamoto J
Cancer Chemother Pharmacol 2009 Nov;64(6):1071-7. Epub 2009 Mar 13 doi: 10.1007/s00280-009-0963-3. PMID: 19283353
Recurrent gastric adenocarcinoma with unusual metastatic localization and excellent response to docetaxel and 5-FU continuous infusion.
Thuss-Patience PC, Kretzschmar A, Krenn V, Dörken B, Reichardt P
Onkologie 2003 Feb;26(1):63-5. doi: 10.1159/000069866. PMID: 12624520
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onoda N, Maeda K, Sawada T, Kato Y, Shirasaka T, Sowa M
Cancer 1997 Jul 1;80(1):1-7. PMID: 9210702

Prognosis

Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.
Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y
Anticancer Res 2019 May;39(5):2583-2589. doi: 10.21873/anticanres.13381. PMID: 31092456
Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?
Chan DY, Syn NL, Yap R, Phua JN, Soh TI, Chee CE, Nga ME, Shabbir A, So JB, Yong WP
J Gastrointest Surg 2017 Mar;21(3):425-433. Epub 2016 Dec 15 doi: 10.1007/s11605-016-3336-3. PMID: 27981493
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
Nakai Y, Ishigami H, Isayama H, Sasaki T, Kawakubo K, Kogure H, Emoto S, Yamaguchi H, Kitayama J, Yamamoto N, Sasahira N, Hirano K, Tada M, Koike K
J Gastroenterol Hepatol 2012 Dec;27(12):1796-800. doi: 10.1111/j.1440-1746.2012.07241.x. PMID: 22849855
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R
Nucl Med Commun 2012 Sep;33(9):960-6. doi: 10.1097/MNM.0b013e328355b694. PMID: 22692579
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onoda N, Maeda K, Sawada T, Kato Y, Shirasaka T, Sowa M
Cancer 1997 Jul 1;80(1):1-7. PMID: 9210702

Clinical prediction guides

Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
Cui Y, Li Q, Yu Y, Chen Y, Feng Y, Wang Y, Liu T
Cancer Chemother Pharmacol 2013 Jan;71(1):145-52. Epub 2012 Oct 12 doi: 10.1007/s00280-012-1991-y. PMID: 23064955
Role of intervention for biliary and gastric/intestinal obstruction in gastric cancer with peritoneal metastasis.
Nakai Y, Ishigami H, Isayama H, Sasaki T, Kawakubo K, Kogure H, Emoto S, Yamaguchi H, Kitayama J, Yamamoto N, Sasahira N, Hirano K, Tada M, Koike K
J Gastroenterol Hepatol 2012 Dec;27(12):1796-800. doi: 10.1111/j.1440-1746.2012.07241.x. PMID: 22849855
18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Sharma P, Singh H, Suman SK, Sharma A, Reddy RM, Thulkar S, Bal C, Malhotra A, Kumar R
Nucl Med Commun 2012 Sep;33(9):960-6. doi: 10.1097/MNM.0b013e328355b694. PMID: 22692579
A phase I study of palliative chemoradiation therapy with paclitaxel and cisplatin for local symptoms due to an unresectable primary advanced or locally recurrent gastric adenocarcinoma.
Yoshikawa T, Tsuburaya A, Hirabayashi N, Yoshida K, Nagata N, Kodera Y, Takahashi N, Oba K, Kimura M, Ishikura S, Miyashita Y, Sakamoto J
Cancer Chemother Pharmacol 2009 Nov;64(6):1071-7. Epub 2009 Mar 13 doi: 10.1007/s00280-009-0963-3. PMID: 19283353
Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma.
Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onoda N, Maeda K, Sawada T, Kato Y, Shirasaka T, Sowa M
Cancer 1997 Jul 1;80(1):1-7. PMID: 9210702

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...